Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 4
2009 13
2010 20
2011 12
2012 16
2013 8
2014 12
2015 12
2016 12
2017 13
2018 7
2019 12
2020 17
2021 23
2022 23
2023 17
2024 25
2025 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Results by year

Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
Agarwal R, Green JB, Heerspink HJL, Mann JFE, McGill JB, Mottl AK, Rosenstock J, Rossing P, Vaduganathan M, Brinker M, Edfors R, Li N, Scheerer MF, Scott C, Nangaku M; CONFIDENCE Investigators. Agarwal R, et al. N Engl J Med. 2025 Aug 7;393(6):533-543. doi: 10.1056/NEJMoa2410659. Epub 2025 Jun 5. N Engl J Med. 2025. PMID: 40470996 Clinical Trial.
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbøll T, Warren ML, Bain SC; PIONEER 6 Investigators. Husain M, et al. N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11. N Engl J Med. 2019. PMID: 31185157 Clinical Trial.
Revisiting hypophosphatemic rickets/osteomalacia.
Bandgar T, Shah N. Bandgar T, et al. Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101859. doi: 10.1016/j.beem.2024.101859. Epub 2024 Jan 6. Best Pract Res Clin Endocrinol Metab. 2024. PMID: 38238129 No abstract available.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics.
Agarwal R, Green JB, Heerspink HJL, Mann JFE, McGill JB, Mottl AK, Rosenstock J, Rossing P, Vaduganathan M, Brinker M, Edfors R, Li N, Scheerer MF, Scott C, Nangaku M; CONFIDENCE investigators. Agarwal R, et al. Nephrol Dial Transplant. 2025 Aug 1;40(8):1559-1569. doi: 10.1093/ndt/gfaf022. Nephrol Dial Transplant. 2025. PMID: 39916475 Free PMC article. Clinical Trial.
Extrapancreatic insulinoma.
Garg R, Memon S, Patil V, Bandgar T. Garg R, et al. Among authors: bandgar t. World J Nucl Med. 2020 Jan 17;19(2):162-164. doi: 10.4103/wjnm.WJNM_41_19. eCollection 2020 Apr-Jun. World J Nucl Med. 2020. PMID: 32939209 Free PMC article.
Sellar Paraganglioma.
Karlekar M, Kumar S, Jadhav S, Lila A, Bandgar T, Shah N. Karlekar M, et al. Among authors: bandgar t. Clin Nucl Med. 2018 Aug;43(8):591-592. doi: 10.1097/RLU.0000000000002157. Clin Nucl Med. 2018. PMID: 29894338
Adolescent primary hyperparathyroidism.
Sharma A, Memon SS, Karlekar M, Bandgar T. Sharma A, et al. Among authors: bandgar t. Best Pract Res Clin Endocrinol Metab. 2025 Mar;39(2):101975. doi: 10.1016/j.beem.2025.101975. Epub 2025 Jan 10. Best Pract Res Clin Endocrinol Metab. 2025. PMID: 39824681 Review.
244 results